Old Web
English
Sign In
Acemap
>
authorDetail
>
Jamie R Doyle
Jamie R Doyle
Vertex Pharmaceuticals
Medicine
Gastroenterology
Placebo
Crossover study
Ivacaftor
2
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation
2020
Journal of Cystic Fibrosis
Gitte Berkers
Renske van der Meer
Harry G.M. Heijerman
Jeffrey M. Beekman
Sylvia F. Boj
Robert G.J. Vries
Peter van Mourik
Jamie R Doyle
Paul K. Audhya
Zheng Jason Yuan
N. Kinnman
C. Kors Van Der Ent
Show All
Source
Cite
Save
Citations (3)
Ivacaftor in People With Cystic Fibrosis and a 3849+10kb C →T or D1152H Residual Function Mutation.
2020
Annals of the American Thoracic Society
Eitan Kerem
Malena Cohen Cymberknoh
Reuven Tsabari
Michael Wilschanski
Joel Reiter
David Shoseyov
Alex Gileles Hillel
Thea Pugatsch
Jane C. Davies
Christopher Short
C Saunders
Cynthia DeSouza
James C. Sullivan
Jamie R Doyle
Keval Chandarana
Nils Kinnman
Show All
Source
Cite
Save
Citations (8)
1